CHINESE MEDICINE (CM) matters by Un, Chun et al.
BioMed  Central
Page 1 of 3
(page number not for citation purposes)
Chinese Medicine
Open Access Editorial
CHINESE MEDICINE (CM) matters
Chun Un, Lorita Cheang, Jerry Lei, Siu-wai Leung and Hin Wing Yeung*
Address: International Society for Chinese Medicine (ISCM), A & C, 1st Floor, Block 2, University of Macau, Av. Padre Tomas Pereira, Taipa, Macao, 
PR China
Email: Chun Un - chun@cmjournal.org; Lorita Cheang - lorita@cmjournal.org; Jerry Lei - jerrylei@cmjournal.org; Siu-
wai Leung - siuwai.leung@cmjournal.org; Hin Wing Yeung* - hwyeung@cmjournal.org
* Corresponding author    
Happy birthday CM! On 23 November 2006, we
launched Chinese Medicine (CM), a peer-reviewed, open
access, international, interdisciplinary and scholarly jour-
nal in Chinese medicine [1]. Two years on, with the best
efforts and sometimes personal sacrifices made by the
authors, editorial and advisory board members, reviewers,
and the editorial teams in Macao and at BioMed Central
in London, we have published a total of thirty-two high
quality research and review articles. In addition, four print
issues have also been distributed to many individuals and
institutions worldwide.
Two years ago, we committed ourselves to publishing val-
uable research in Chinese medicine. We appreciate all rig-
orous research methodologies and evidence, whether they
are traditional or modern, conventional or alternative,
macroscopic or microscopic. All articles (except editori-
als) published in CM must be peer-reviewed to ensure that
they are evidence-based, scientifically justified and ethi-
cal. A total of thirteen review articles and eighteen research
articles and one editorial have been published. They are
important contributions to Chinese medicine, covering a
wide range of topics/interests such as acupuncture, materia
medica, Chinese medicine formulae, dentistry, allergy,
metabonomics, genomics, cardiovascular diseases, liver
diseases, cancer, arthritis, ageing, quality control and drug
safety, and more. They have been highly accessed and
widely cited. As they are indexed and permanently
archived by major international scientific repositories and
web-based search engines for e-journals such as PubMed,
PubMed Central, Potsdam, INIST, e-Depot, CAS, CABI,
Citebase, OAIster, Cinahl, Scopus, Scirus, Google Scholar
and Zetoc, the general public as well as Chinese medicine
researchers can always access them for information and
reference.
Not surprisingly, CM published articles on ginseng – a hot
research topic. Yue et al. [2] relate the pharmacogenomics
of ginseng to 'Yin and Yang' actions, particularly the anti-
tumor, angiomodulating and steroid-like activities of gin-
senosides. Mechanistic and functional genomic studies
revealed that a group of genes were regulated by ginseno-
sides in endothelial cells and ginsenosides (Rb1 and Rg1)
with opposing activities. Moreover, the authors demon-
strate that ginsenosides can act as functional ligands to
activate different steroid hormone receptors. Such
research findings may help discover the mystery of the
diverse pharmacological activities and therapeutic effects
of ginseng. The 'Ying and Yang' actions of ginseng, partic-
ularly ginsenosides (Re and Rg3), as reported by Ng et al.
[3], alter cellular redox state of a tumour cell model in
opposite directions. Equally fascinating accounts are
given by Ko et al. [4] relating the ancient ideas of Yin and
Yang in Chinese medicine to the biological concepts of
ATP generation, antioxidant and immunomodulation.
Wu et al. [5] also introduce us to the modulating effects of
American ginseng on pancreatic beta cell activities.
As a natural and holistic approach, traditional Chinese
herbal medicine often uses formulae consisting of multi-
ple herbs. The complexity of Chinese medicine formulae
is a big technical challenge to the research and quality
assurance/control of herbal products. CM has published
six articles to address this issue including the compound-
oriented and pattern-oriented approaches [6], DNA meth-
ods for identification of Chinese medicinal materials [7],
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chemical markers for the quality control of herbal medi-
cines [8], the applications of high-performance liquid
chromatograph (HPLC) method in the quality assurance
of complex Chinese medicine formulae Dachenggi Tang
[9], Gegen Tang granule [10] and herbal products of Radix
Aconiti Lateralis Perarata [11]. CM has also published sev-
eral studies on the complexity of multiple herb formulae,
e.g. a systematic approach to revealing the complexity of
Chinese herbal medicine formulae [12], an animal study
of Yinchenhao Tang on cirrhosis/fibrosis [13] and a clinical
study on Duhuo Jisheng Tang for treating osteoarthritis
[14].
Clinical studies in Chinese medicine are often not well
reported. We have been trying to improve the situation by
enforcing the international standards of clinical trial
reporting in our published articles. Capodice et al. [15]
and Itoh et al. [16] report the applications of acupuncture
to treat lower urinary tract symptoms related to chronic
prostatitis/chronic pelvic pain and knee osteoarthritis
respectively. Another clinical study on treating knee oste-
oarthritis with Chinese herbal medicine is reported by Lai
et al. [14]. A meta-analysis by Liu et al. [17] assesses the
effectiveness and safety of Chinese red yeast rice prepara-
tions on lipid modification in primary hyperlipidemia. A
systematic review by Liu et al. [18] investigates the benefi-
cial effects of green tea on caner prevention by evaluating
forty-three epidemiological studies, four randomized tri-
als and one meta-analysis.
In a review article, Wang et al. [19] survey the literature for
a list of Chinese herbal ingredients with reported liver
protection activities, in which a total of 274 different spe-
cies and hundreds of active ingredients were examined. In
another review article, Adams et al. [20] discuss the phar-
macology, medicinal chemistry and clinical studies pub-
lished for danshen and tanshinone preparations. Itokawa
et al. [21] survey the literature between 1976 and mid-
2008 on the anti-inflammatory, anti-oxidant, anti-HIV,
chemopreventive and anti-prostate cancer effects of curcu-
minoids.
On the front of the so-called 'omics', Qiu et al. [22] dem-
onstrate that metabolic profiling is useful in studying
therapeutic mechanisms of herbal medicines such as
Herba Cistanches. The Faculty of Dentistry of the Univer-
sity of Hong Kong has contributed two articles to CM on
bone formation authored by Wong et al. [23,24]. We hope
that this series of papers will bear the fruit of a newly pro-
posed research discipline, dubbed as Evidence-based Inte-
grative Dentistry (EBID). CM encourages submissions in
this emerging field.
Two years ago, we committed ourselves to the internation-
alization and modernization of Chinese medicine [1].
Today, we boast a much internationalized authorship in
the Chinese medicine field. The authorship of the pub-
lished articles covers thirteen countries and regions. We
are also proud of the support from the leading scholars
and experts in Chinese medicine and integrative medicine
serving as our advisory/editorial board members and/or
our reviewers.
As of 28 November 2008, the acceptance rate of CM dur-
ing this two-year period has been 20.13%. In our editorial
work, we recognize a great demand for improving English
writing skills that are crucial to reporting research find-
ings. We have been providing our authors with extensive
English writing assistance and copy-editing, which is why
some papers took longer time to publish. We are also
planning a scientific writing workshop to help the authors
in need.
Two years ago, we committed ourselves to Open Access to
'ensure that the best Chinese medicine research is pub-
lished and read by the widest possible range of interna-
tional audience' and that 'in a speedy and professional
manner, the scientific value and potential impact of all
published articles in CM will be judged and evaluated by
the international scientific community' [1]. Today, access
and citation data speak for themselves. As of 28 Novem-
ber 2008, the two most viewed articles of all time have
recorded access numbers of 14,527 and 10,396 respec-
tively. Eleven out of the thirty-two articles published have
been cited and the total number of citations has
amounted to 36. The two most cited articles have been
cited eight and five times respectively. Recently published
articles have also been cited. The access and citation data
show that the articles published in CM have high interna-
tional visibility and accessibility and are tremendously
citation friendly as stated in our launch editorial [1]. The
data also support that open access articles are immediately
read and cited by peers, leading to a quicker and higher
number of citations [25-27].
For the future, we strongly encourage our authors to fol-
low the international guidelines for scientific reporting
when they submit a manuscript, while rigorous reviews of
manuscripts must also be upheld. We firmly believe that
the synergy generated by the authors, reviewers and edi-
tors will enable this journal to publish more and better
papers. We are more convinced now than two years ago
that this journal is an exciting medium for fostering open
access strengths and evidence-led forces for the advance-
ment of Chinese medicine [1].
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